Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q2 · 3,1 OA 14 matched articles SCIE

Journal detail

International Journal of Hypertension

Publisher
John Wiley and Sons Ltd
Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 20900384
  • 20900392
Scopus 0,598 SJR
Scopus Q2 SJR Q
WoS Q2 JCR Q
WoS 3,1 JIF
Scopus 54 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,598
  • Quartile Q2
  • H-Index 54
  • Cites/doc 3,71
  • Docs (3y) 77
  • Cites (3y) 190

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 3,1
  • 5Y JIF 2,4
  • JCI 0,45

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Internal Medicine Q2

Areas

  • Medicine

WoS categories

  • Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q2 0,598 3,1 2,4 0,45 Q3 54
2024 Q2 Q3 0,602 1,7 2 0,42 Q3 51
2023 Q3 Q3 0,482 1,9 2,1 0,39 Q3 51
2022 Q3 Q4 0,464 1,9 2,5 0,41 Q3 51
2021 Q2 Q3 0,604 2,4 2,9 0,43 Q3 51
2020 Q2 Q3 0,744 2,4 2,8 0,43 Q3 51
2019 Q3 Q4 0,563 1,1 0,31 Q4 51
2018 Q3 1,9 0,38 Q3
2017 Q2 Q3 0,578 1,6 0,37 Q4 51
2016 Q2 0,793 51
2015 Q2 0,858 51
2014 Q2 0,817 51
2013 Q2 0,749 51
2012 Q2 0,582 51
2011 Q2 0,313 51
2010 51

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q3 36/100
2024 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 68/98
2023 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 57/96
2022 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q3 52/68
2021 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 49/67
2020 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 45/65
2019 PERIPHERAL VASCULAR DISEASE SCIE Q4 Q4 61/65
2018 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 45/65
2017 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q4 48/65